The Role of Progranulin (PGRN) in the Pathogenesis of Ischemic Stroke.


Journal

Cellular and molecular neurobiology
ISSN: 1573-6830
Titre abrégé: Cell Mol Neurobiol
Pays: United States
ID NLM: 8200709

Informations de publication

Date de publication:
Oct 2023
Historique:
received: 11 12 2022
accepted: 28 07 2023
medline: 5 9 2023
pubmed: 10 8 2023
entrez: 10 8 2023
Statut: ppublish

Résumé

Stroke is a life-threatening medical condition and is a leading cause of disability. Cerebral ischemia is characterized by a distinct inflammatory response starting with the production of various cytokines and other inflammation-related agents. Progranulin (PGRN), a multifunctional protein, is critical in diverse physiological reactions, such as cell proliferation, inflammation, wound healing, and nervous system development. A mature PGRN is anti-inflammatory, while granulin, its derivative, conversely induces pro-inflammatory cytokine expression. PGRN is significantly involved in the brain tissue and its damage, for example, improving mood and cognitive disorders caused by cerebral ischemia. It may also have protective effects against nerve and spinal cord injuries by inhibiting neuroinflammatory response and apoptosis or it may be related to the proliferation, accumulation, differentiation, and activation of microglia. PGRN is a neurotrophic factor in the central nervous system. It may increase post-stroke neurogenesis of the subventricular zone (SVZ), which is particularly important in improving long-term brain function following cerebral ischemia. The neurogenesis enhanced via PGRN in the ischemic brain SVZ may be attributed to the induction of PI3K/AKT and MAPK/ERK signaling routes. PGRN can also promote the proliferation of neural stem/progenitor cells through PI3K/AKT signaling pathway. PGRN increases hippocampal neurogenesis, reducing anxiety and impaired spatial learning post-cerebral ischemia. PGRN alleviates cerebral ischemia/reperfusion injury by reducing endoplasmic reticulum stress and suppressing the NF-κB signaling pathway. PGRN can be introduced as a potent neuroprotective agent capable of improving post-ischemia neuronal actions, mainly by reducing and elevating the inflammatory and anti-inflammatory cytokines. Expression, storage, cleavage, and function of progranulin (PGRN) in the pathogenesis of ischemic stroke.

Identifiants

pubmed: 37561339
doi: 10.1007/s10571-023-01396-8
pii: 10.1007/s10571-023-01396-8
doi:

Substances chimiques

Progranulins 0
Proto-Oncogene Proteins c-akt EC 2.7.11.1
Phosphatidylinositol 3-Kinases EC 2.7.1.-
Cytokines 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

3435-3447

Informations de copyright

© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Références

Almeida S, Zhou L, Gao F-B (2011) Progranulin, a glycoprotein deficient in frontotemporal dementia, is a novel substrate of several protein disulfide isomerase family proteins. PLoS ONE 6(10):e26454
pubmed: 22028881 pmcid: 3196579 doi: 10.1371/journal.pone.0026454
Amantea D, Nappi G, Bernardi G, Bagetta G, Corasaniti MT (2009) Post-ischemic brain damage: pathophysiology and role of inflammatory mediators. FEBS J 276(1):13–26
pubmed: 19087196 doi: 10.1111/j.1742-4658.2008.06766.x
Anacker C, Hen R (2017) Adult hippocampal neurogenesis and cognitive flexibility—linking memory and mood. Nat Rev Neurosci 18(6):335–346
pubmed: 28469276 pmcid: 6261347 doi: 10.1038/nrn.2017.45
Anakwe O, Gerton GL (1989) Acrosome biogenesis begins during meiosis: evidence from the synthesis and distribution of an acrosomal glycoprotein, acrogranin, during guinea pig spermatogenesis. Biol Reprod 42(2):317–328
doi: 10.1095/biolreprod42.2.317
Arango-Dávila CA, Vera A, Londoño AC, Echeverri A, Cañas F, Cardozo C et al (2015) Soluble or soluble/membrane TNF-±inhibitors protect the brain from focal ischemic injury in rats. Int J Neurosci 125(12):936–940
pubmed: 25350870 doi: 10.3109/00207454.2014.980906
Arechavaleta-Velasco F, Perez-Juarez CE, Gerton GL, Diaz-Cueto L (2017) Progranulin and its biological effects in cancer. Med Oncol 34:1–11
doi: 10.1007/s12032-017-1054-7
Back T (1998) Pathophysiology of the ischemic penumbra—revision of a concept. Cell Mol Neurobiol 18:621–638
pubmed: 9876870 doi: 10.1023/A:1020629818207
Baker M, Mackenzie IR, Pickering-Brown SM, Gass J, Rademakers R, Lindholm C et al (2006) Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature 442(7105):916–919
pubmed: 16862116 doi: 10.1038/nature05016
Benjamin EJ, Muntner P, Alonso A, Bittencourt MS, Callaway CW, Carson AP et al (2019) Heart disease and stroke statistics—2019 update: a report from the American Heart Association. Circulation 139(10):e56–e528
pubmed: 30700139 doi: 10.1161/CIR.0000000000000659
Berkhemer OA, Fransen PS, Beumer D, Van Den Berg LA, Lingsma HF, Yoo AJ et al (2015) A randomized trial of intraarterial treatment for acute ischemic stroke. Engl J Med 372:11–20
doi: 10.1056/NEJMoa1411587
Block F (1999) Global ischemia and behavioural deficits. Prog Neurobiol 58(3):279–295
pubmed: 10341364 doi: 10.1016/S0301-0082(98)00085-9
Broocks G, Jafarov H, McDonough R, Austein F, Meyer L, Bechstein M et al (2021) Relationship between the degree of recanalization and functional outcome in acute ischemic stroke is mediated by penumbra salvage volume. J Neurol 268:2213–2222
pubmed: 33486602 pmcid: 8179901 doi: 10.1007/s00415-021-10410-2
Buttini M, Appel K, Sauter A, Gebicke-Haerter P-J, Boddeke H (1996) Expression of tumor necrosis factor alpha after focal cerebral ischaemia in the rat. Neuroscience 71(1):1–16
pubmed: 8834388 doi: 10.1016/0306-4522(95)00414-9
Chen C-J, Liao S-L, Chen W-Y, Hong J-S, Kuo J-S (2001) Cerebral ischemia/reperfusion injury in rat brain: effects of naloxone. NeuroReport 12(6):1245–1249
pubmed: 11338200 doi: 10.1097/00001756-200105080-00038
Chen L, Li Q, Wang J, Jin S, Zheng H, Lin J et al (2017) MiR-29b-3p promotes chondrocyte apoptosis and facilitates the occurrence and development of osteoarthritis by targeting PGRN. J Cell Mol Med 21(12):3347–3359
pubmed: 28609022 pmcid: 5706578 doi: 10.1111/jcmm.13237
Chen T, Shi R, Suo Q, Wu S, Liu C, Huang S et al (2023) Progranulin released from microglial lysosomes reduces neuronal ferroptosis after cerebral ischemia in mice. J Cereb Blood Flow Metab 43(4):505–517
pubmed: 36514959 doi: 10.1177/0271678X221145090
Chiba S, Suzuki M, Yamanouchi K, Nishihara M (2007) Involvement of granulin in estrogen-induced neurogenesis in the adult rat hippocampus. J Reprod Dev 53(2):297–307
pubmed: 17179653 doi: 10.1262/jrd.18108
Chinnaiyan AM, O’Rourke K, Yu G-L, Lyons RH, Garg M, Duan DR et al (1996) Signal transduction by DR3, a death domain-containing receptor related to TNFR-1 and CD95. Science 274(5289):990–992
pubmed: 8875942 doi: 10.1126/science.274.5289.990
Chitramuthu B, Bateman A (2016) Progranulin and the receptor tyrosine kinase EphA2, partners in crime? J Cell Biol 215(5):603
pubmed: 27903608 pmcid: 5147006 doi: 10.1083/jcb.201610097
Cruts M, Gijselinck I, Van Der Zee J, Engelborghs S, Wils H, Pirici D et al (2006) Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21. Nature 442(7105):920–924
pubmed: 16862115 doi: 10.1038/nature05017
Cui Y, Hettinghouse A, Cj L (2019) Progranulin: a conductor of receptors orchestra, a chaperone of lysosomal enzymes and a therapeutic target for multiple diseases. Cytokine Growth Factor Rev 45:53–64
pubmed: 30733059 pmcid: 6450552 doi: 10.1016/j.cytogfr.2019.01.002
Deb P, Sharma S, Hassan K (2010) Pathophysiologic mechanisms of acute ischemic stroke: an overview with emphasis on therapeutic significance beyond thrombolysis. Pathophysiology 17(3):197–218
pubmed: 20074922 doi: 10.1016/j.pathophys.2009.12.001
Degterev A, Huang Z, Boyce M, Li Y, Jagtap P, Mizushima N et al (2005) Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury. Nat Chem Biol 1(2):112–119
pubmed: 16408008 doi: 10.1038/nchembio711
Deng X-X, Li S-S, Sun F-Y (2019) Necrostatin-1 prevents necroptosis in brains after ischemic stroke via inhibition of RIPK1-mediated RIPK3/MLKL signaling. Aging Dis 10(4):807
pubmed: 31440386 pmcid: 6675533 doi: 10.14336/AD.2018.0728
Dong T, Tejwani L, Jung Y, Kokubu H, Luttik K, Driessen TM et al (2021) Microglia regulate brain progranulin levels through the endocytosis/lysosomal pathway. JCI Insight. https://doi.org/10.1172/jci.insight.136147
doi: 10.1172/jci.insight.136147 pubmed: 34877932 pmcid: 8675193
Egashira Y, Suzuki Y, Azuma Y, Takagi T, Mishiro K, Sugitani S et al (2013) The growth factor progranulin attenuates neuronal injury induced by cerebral ischemia-reperfusion through the suppression of neutrophil recruitment. J Neuroinflammation 10(1):1–13
doi: 10.1186/1742-2094-10-105
ElAli A, Jean LN (2016) The role of monocytes in ischemic stroke pathobiology: new avenues to explore. Front Aging Neurosci 8:29
pubmed: 26941641 pmcid: 4761876 doi: 10.3389/fnagi.2016.00029
Elmore SA, Dixon D, Hailey JR, Harada T, Herbert RA, Maronpot RR et al (2016) Recommendations from the INHAND apoptosis/necrosis working group. Toxicol Pathol 44(2):173–188
pubmed: 26879688 pmcid: 4785073 doi: 10.1177/0192623315625859
Eriksen JL, Mackenzie IR (2008) Progranulin: normal function and role in neurodegeneration. J Neurochem 104(2):287–297
pubmed: 17953663
Evers BM, Rodriguez-Navas C, Tesla RJ, Prange-Kiel J, Wasser CR, Yoo KS et al (2017) Lipidomic and transcriptomic basis of lysosomal dysfunction in progranulin deficiency. Cell Rep 20(11):2565–2574
pubmed: 28903038 pmcid: 5757843 doi: 10.1016/j.celrep.2017.08.056
Feigin VL, Stark BA, Johnson CO, Roth GA, Bisignano C, Abady GG et al (2021) Global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Neurol 20(10):795–820
doi: 10.1016/S1474-4422(21)00252-0
Gao X, Joselin AP, Wang L, Kar A, Ray P, Bateman A et al (2010) Progranulin promotes neurite outgrowth and neuronal differentiation by regulating GSK-3β. Protein Cell 1:552–562
pubmed: 21204008 pmcid: 4875315 doi: 10.1007/s13238-010-0067-1
Gencoglu H, Orhan C, Sahin K (2017) Phytochemical therapies in vascular functioning: a molecular approach. Curr Vasc Pharmacol 15(4):327–338
pubmed: 28056757 doi: 10.2174/1570161115666170105122616
Gidday JM, Gasche YG, Copin J-C, Shah AR, Perez RS, Shapiro SD et al (2005) Leukocyte-derived matrix metalloproteinase-9 mediates blood-brain barrier breakdown and is proinflammatory after transient focal cerebral ischemia. Am J Physiol-Heart Circ Physiol 289(2):H558–H568
pubmed: 15764676 doi: 10.1152/ajpheart.01275.2004
Goldstein LB (2020) Introduction for focused updates in cerebrovascular disease. Stroke 51(3):708–710
pubmed: 32078448 doi: 10.1161/STROKEAHA.119.024159
Guo S, Stins M, Ning M, Lo EH (2010) Amelioration of inflammation and cytotoxicity by dipyridamole in brain endothelial cells. Cerebrovasc Dis 30(3):290–296
pubmed: 20664263 pmcid: 3214842 doi: 10.1159/000319072
Hacke W, Kaste M, Bluhmki E, Brozman M, Dávalos A, Guidetti D et al (2008) Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. New Engl J Med 359(13):1317–1329
pubmed: 18815396 doi: 10.1056/NEJMoa0804656
Hallenbeck JM (1996) Inflammatory reactions at the blood-endothelial interface in acute stroke. Adv Neurol 71:281–297
pubmed: 8790806
Hankey G (2017) Stroke. Lancet 389(10069):641–654
pubmed: 27637676 doi: 10.1016/S0140-6736(16)30962-X
He Z, Ong CH, Halper J, Bateman A (2003) Progranulin is a mediator of the wound response. Nat Med 9(2):225–229
pubmed: 12524533 doi: 10.1038/nm816
He Y, Chen S, Tsoi B, Qi S, Gu B, Wang Z et al (2021) Alpinia oxyphylla Miq. and its active compound P-Coumaric acid promote brain-derived neurotrophic factor signaling for inducing hippocampal neurogenesis and improving post-cerebral ischemic spatial cognitive functions. Front Cell Dev Biol 8:577790
pubmed: 33537297 pmcid: 7849625 doi: 10.3389/fcell.2020.577790
Hermey G (2009) The Vps10p-domain receptor family. Cell Mol Life Sci 66(16):2677–2689
pubmed: 19434368 doi: 10.1007/s00018-009-0043-1
Horinokita I, Hayashi H, Oteki R, Mizumura R, Yamaguchi T, Usui A et al (2019) Involvement of progranulin and granulin expression in inflammatory responses after cerebral ischemia. Int J Mol Sci 20(20):5210
pubmed: 31640144 pmcid: 6829276 doi: 10.3390/ijms20205210
Horinokita I, Hayashi H, Nagatomo T, Fushiki Y, Iwatani Y, Takagi N (2022) Effect of progranulin on proliferation and differentiation of neural stem/progenitor cells after oxygen/glucose deprivation. Int J Mol Sci 23(4):1949
pubmed: 35216064 pmcid: 8879483 doi: 10.3390/ijms23041949
Hwang H-J, Jung TW, Hong HC, Choi HY, Seo J-A, Kim SG et al (2013) Progranulin protects vascular endothelium against atherosclerotic inflammatory reaction via Akt/eNOS and nuclear factor-κB pathways. PLoS ONE 8(9):e76679
pubmed: 24098801 pmcid: 3786912 doi: 10.1371/journal.pone.0076679
Jackman K, Kahles T, Lane D, Garcia-Bonilla L, Abe T, Capone C et al (2013) Progranulin deficiency promotes post-ischemic blood–brain barrier disruption. J Neurosci 33(50):19579–19589
pubmed: 24336722 pmcid: 3858627 doi: 10.1523/JNEUROSCI.4318-13.2013
Jin R, Yang G, Li G (2010) Inflammatory mechanisms in ischemic stroke: role of inflammatory cells. J Leukoc Biol 87(5):779–789
pubmed: 20130219 pmcid: 2858674 doi: 10.1189/jlb.1109766
Kadry H, Noorani B, Cucullo L (2020) A blood–brain barrier overview on structure, function, impairment, and biomarkers of integrity. Fluids Barriers CNS 17(1):1–24
doi: 10.1186/s12987-020-00230-3
Kanazawa M, Kawamura K, Takahashi T, Miura M, Tanaka Y, Koyama M et al (2015) Multiple therapeutic effects of progranulin on experimental acute ischaemic stroke. Brain 138(7):1932–1948
pubmed: 25838514 doi: 10.1093/brain/awv079
Kanazawa M, Ninomiya I, Hatakeyama M, Takahashi T, Shimohata T (2017) Microglia and monocytes/macrophages polarization reveal novel therapeutic mechanism against stroke. Int J Mol Sci 18(10):2135
pubmed: 29027964 pmcid: 5666817 doi: 10.3390/ijms18102135
Kang W, Hébert JM (2011) Signaling pathways in reactive astrocytes, a genetic perspective. Mol Neurobiol 43:147–154
pubmed: 21234816 pmcid: 3087829 doi: 10.1007/s12035-011-8163-7
Kataoka H, Kim S-W, Plesnila N (2004) Leukocyte-endothelium interactions during permanent focal cerebral ischemia in mice. J Cereb Blood Flow Metab 24(6):668–676
pubmed: 15181374 doi: 10.1097/01.WCB.0000117812.35136.5B
Kessenbrock K, Fröhlich L, Sixt M, Lämmermann T, Pfister H, Bateman A et al (2008) Proteinase 3 and neutrophil elastase enhance inflammation in mice by inactivating antiinflammatory progranulin. J Clin Investig 118(7):2438–2447
pubmed: 18568075 pmcid: 2430496
Kishimoto TK, Rothlein R (1994) Integrins, ICAMs, and selectins: role and regulation of adhesion molecules in neutrophil recruitment to inflammatory sites. Adv Pharmacol 25:117–169
pubmed: 7515640 doi: 10.1016/S1054-3589(08)60431-7
Kleinberger G, Wils H, Ponsaerts P, Joris G, Timmermans JP, Van Broeckhoven C et al (2010) Increased caspase activation and decreased TDP-43 solubility in progranulin knockout cortical cultures. J Neurochem 115(3):735–747
pubmed: 20731760 doi: 10.1111/j.1471-4159.2010.06961.x
Kochanek PM, Hallenbeck JM (1992) Polymorphonuclear leukocytes and monocytes/macrophages in the pathogenesis of cerebral ischemia and stroke. Stroke 23(9):1367–1379
pubmed: 1519296 doi: 10.1161/01.STR.23.9.1367
Koh S-H, Park H-H (2017) Neurogenesis in stroke recovery. Transl Stroke Res 8:3–13
pubmed: 26987852 doi: 10.1007/s12975-016-0460-z
Kriz J (2006) Inflammation in ischemic brain injury: timing is important. Crit Rev™ Neurobiol 18(1–2):145
pubmed: 17725517 doi: 10.1615/CritRevNeurobiol.v18.i1-2.150
Kuse Y, Tsuruma K, Sugitani S, Izawa H, Ohno Y, Shimazawa M et al (2016) Progranulin promotes the retinal precursor cell proliferation and the photoreceptor differentiation in the mouse retina. Sci Rep 6(1):23811
pubmed: 27030285 pmcid: 4814875 doi: 10.1038/srep23811
Laird AS, Van Hoecke A, De Muynck L, Timmers M, Van Den Bosch L, Van Damme P et al (2010) Progranulin is neurotrophic in vivo and protects against a mutant TDP-43 induced axonopathy. PLoS ONE 5(10):e13368
pubmed: 20967127 pmcid: 2954192 doi: 10.1371/journal.pone.0013368
Lambertsen KL, Biber K, Finsen B (2012) Inflammatory cytokines in experimental and human stroke. J Cereb Blood Flow Metab 32(9):1677–1698
pubmed: 22739623 pmcid: 3434626 doi: 10.1038/jcbfm.2012.88
Li X, Cheng S, Hu H, Zhang X, Xu J, Wang R et al (2020) Progranulin protects against cerebral ischemia-reperfusion (I/R) injury by inhibiting necroptosis and oxidative stress. Biochem Biophys Res Commun 521(3):569–576
pubmed: 31679689 doi: 10.1016/j.bbrc.2019.09.111
Liaw N, Liebeskind D (2020) Emerging therapies in acute ischemic stroke. F1000Research 9:546
doi: 10.12688/f1000research.21100.1
Liberale L, Bonetti NR, Puspitasari YM, Vukolic A, Akhmedov A, Diaz-Cañestro C et al (2021) TNF-α antagonism rescues the effect of ageing on stroke: Perspectives for targeting inflamm-ageing. Eur J Clin Invest 51(11):e13600
pubmed: 34076259 pmcid: 8596431 doi: 10.1111/eci.13600
Lisman J, Buzsáki G, Eichenbaum H, Nadel L, Ranganath C, Redish AD (2017) Viewpoints: how the hippocampus contributes to memory, navigation and cognition. Nat Neurosci 20(11):1434–1447
pubmed: 29073641 pmcid: 5943637 doi: 10.1038/nn.4661
Liu C-j, Progranulin BX (2012) a growth factor, a novel TNFR ligand and a drug target. Pharmacol Ther 133(1):124–132
pubmed: 22008260 doi: 10.1016/j.pharmthera.2011.10.003
Liu C, Li X-X, Gao W, Liu W, Liu D-S (2014) Progranulin-derived Atsttrin directly binds to TNFRSF25 (DR3) and inhibits TNF-like ligand 1A (TL1A) activity. PLoS ONE 9(3):e92743
pubmed: 24651300 pmcid: 3961393 doi: 10.1371/journal.pone.0092743
Liu B, Zhang Y-h, Jiang Y, Li L-1, Chen Q, G-q He et al (2015) Gadd45b is a novel mediator of neuronal apoptosis in ischemic stroke. Int J Biol Sci 11(3):353
pubmed: 25678854 pmcid: 4323375 doi: 10.7150/ijbs.9813
Liu Y, Ren J, Kang M, Zhai C, Cheng Q, Li J et al (2021) Progranulin promotes functional recovery and neurogenesis in the subventricular zone of adult mice after cerebral ischemia. Brain Res 1757:147312
pubmed: 33539798 doi: 10.1016/j.brainres.2021.147312
Lockshin R (2016) Programmed cell death 50 (and beyond). Cell Death Differ 23(1):10–17
pubmed: 26564398 doi: 10.1038/cdd.2015.126
Lü L, Luo L, Lu Y, Chen L, Xu J, Guo K (2013) Progranulin expression in neural stem cells and their differentiated cell lineages: an immunocytochemical study. Mol Med Rep 8(5):1359–1364
pubmed: 24002337 doi: 10.3892/mmr.2013.1664
Lui H, Zhang J, Makinson SR, Cahill MK, Kelley KW, Huang H-Y et al (2016) Progranulin deficiency promotes circuit-specific synaptic pruning by microglia via complement activation. Cell 165(4):921–935
pubmed: 27114033 pmcid: 4860138 doi: 10.1016/j.cell.2016.04.001
Ma Y, Matsuwaki T, Yamanouchi K, Nishihara M (2017) Progranulin protects hippocampal neurogenesis via suppression of neuroinflammatory responses under acute immune stress. Mol Neurobiol 54:3717–3728
pubmed: 27215202 doi: 10.1007/s12035-016-9939-6
Mackenzie IR (2007) The neuropathology and clinical phenotype of FTD with progranulin mutations. Acta Neuropathol 114:49–54
pubmed: 17458552 doi: 10.1007/s00401-007-0223-8
Murai KK, Pasquale EB (2004) Eph receptors, ephrins, and synaptic function. Neuroscientist 10(4):304–314
pubmed: 15271258 doi: 10.1177/1073858403262221
Nalls MA, Blauwendraat C, Sargent L, Vitale D, Leonard H, Iwaki H et al (2021) Evidence for GRN connecting multiple neurodegenerative diseases. Brain Commun 3(2):fcab095
pubmed: 34693284 pmcid: 8134835 doi: 10.1093/braincomms/fcab095
Nedachi T, Kawai T, Matsuwaki T, Yamanouchi K, Nishihara M (2011) Progranulin enhances neural progenitor cell proliferation through glycogen synthase kinase 3β phosphorylation. Neuroscience 185:106–115
pubmed: 21540081 doi: 10.1016/j.neuroscience.2011.04.037
Neill T, Buraschi S, Goyal A, Sharpe C, Natkanski E, Schaefer L et al (2016) EphA2 is a functional receptor for the growth factor progranulin. J Cell Biol 215(5):687–703
pubmed: 27903606 pmcid: 5146997 doi: 10.1083/jcb.201603079
Nguyen AD, Nguyen TA, Martens LH, Mitic LL, Farese RV Jr (2013) Progranulin: at the interface of neurodegenerative and metabolic diseases. Trends Endocrinol Metab 24(12):597–606
pubmed: 24035620 doi: 10.1016/j.tem.2013.08.003
Ornello R, Degan D, Tiseo C, Di Carmine C, Perciballi L, Pistoia F et al (2018) Distribution and temporal trends from 1993 to 2015 of ischemic stroke subtypes: a systematic review and meta-analysis. Stroke 49(4):814–819
pubmed: 29535272 doi: 10.1161/STROKEAHA.117.020031
Pan W, Kastin AJ (2007) Tumor necrosis factor and stroke: role of the blood–brain barrier. Prog Neurobiol 83(6):363–374
pubmed: 17913328 pmcid: 2190541 doi: 10.1016/j.pneurobio.2007.07.008
Petkau TL, Neal S, Orban P, MacDonald J, Hill A, Lu G et al (2010) Progranulin expression in the developing and adult murine brain. J Comp Neurol 518(19):3931–3947
pubmed: 20737593 doi: 10.1002/cne.22430
Pickford F, Marcus J, Camargo LM, Xiao Q, Graham D, Mo J-R et al (2011) Progranulin is a chemoattractant for microglia and stimulates their endocytic activity. Am J Pathol 178(1):284–295
pubmed: 21224065 pmcid: 3070582 doi: 10.1016/j.ajpath.2010.11.002
Plowman GD, Green JM, Neubauer MG, Buckley SD, McDonald VL, Todaro GJ et al (1992) The epithelin precursor encodes two proteins with opposing activities on epithelial cell growth. J Biol Chem 267(18):13073–13078
pubmed: 1618805 doi: 10.1016/S0021-9258(18)42382-4
Raitano S, Ordovàs L, De Muynck L, Guo W, Espuny-Camacho I, Geraerts M et al (2015) Restoration of progranulin expression rescues cortical neuron generation in an induced pluripotent stem cell model of frontotemporal dementia. Stem Cell Rep 4(1):16–24
doi: 10.1016/j.stemcr.2014.12.001
Rhinn H, Tatton N, McCaughey S, Kurnellas M, Rosenthal A (2022) Progranulin as a therapeutic target in neurodegenerative diseases. Trends Pharmacol Sci 43(8):641–652
pubmed: 35039149 doi: 10.1016/j.tips.2021.11.015
Rodriguez D, Weinlich R, Brown S, Guy C, Fitzgerald P, Dillon C et al (2016) Characterization of RIPK3-mediated phosphorylation of the activation loop of MLKL during necroptosis. Cell Death Differ 23(1):76–88
pubmed: 26024392 doi: 10.1038/cdd.2015.70
Saini V, Guada L, Yavagal DR (2021) Global epidemiology of stroke and access to acute ischemic stroke interventions. Neurology 97(20 Supplement 2):S6–S16
pubmed: 34785599 doi: 10.1212/WNL.0000000000012781
Schaller B, Graf R (2004) Cerebral ischemia and reperfusion: the pathophysiologic concept as a basis for clinical therapy. J Cereb Blood Flow Metab 24(4):351–371
pubmed: 15087705 doi: 10.1097/00004647-200404000-00001
Shankaran SS, Capell A, Hruscha AT, Fellerer K, Neumann M, Schmid B et al (2008) Missense mutations in the progranulin gene linked to frontotemporal lobar degeneration with ubiquitin-immunoreactive inclusions reduce progranulin production and secretion. J Biol Chem 283(3):1744–1753
pubmed: 17984093 doi: 10.1074/jbc.M705115200
Shioda N, Han F, Fukunaga K (2009) Role of Akt and ERK signaling in the neurogenesis following brain ischemia. Int Rev Neurobiol 85:375–387
pubmed: 19607982 doi: 10.1016/S0074-7742(09)85026-5
Şimsek Z, Alizade E, Abdurahmanova İ, Güner A, Zehir R, Pala S (2023) Serum sortilin as a predictor of stroke in patients with intermediate carotid artery stenosis. Vascular 31(2):317–324
pubmed: 35403511 doi: 10.1177/17085381211067051
Soares LM, Schiavon AP, Milani H, de Oliveira RMW (2013) Cognitive impairment and persistent anxiety-related responses following bilateral common carotid artery occlusion in mice. Behav Brain Res 249:28–37
pubmed: 23602921 doi: 10.1016/j.bbr.2013.04.010
Soares LM, De Vry J, Steinbusch HW, Milani H, Prickaerts J, De Oliveira RMW (2016) Rolipram improves cognition, reduces anxiety-and despair-like behaviors and impacts hippocampal neuroplasticity after transient global cerebral ischemia. Neuroscience 326:69–83
pubmed: 27058148 doi: 10.1016/j.neuroscience.2016.03.062
Stoll G, Jander S, Schroeter M (1998) Inflammation and glial responses in ischemic brain lesions. Prog Neurobiol 56(2):149–171
pubmed: 9760699 doi: 10.1016/S0301-0082(98)00034-3
Su X, Wang H, Kang D, Zhu J, Sun Q, Li T et al (2015) Necrostatin-1 ameliorates intracerebral hemorrhage-induced brain injury in mice through inhibiting RIP1/RIP3 pathway. Neurochem Res 40:643–650
pubmed: 25576092 doi: 10.1007/s11064-014-1510-0
Suh H-S, Choi N, Tarassishin L, Lee SC (2012) Regulation of progranulin expression in human microglia and proteolysis of progranulin by matrix metalloproteinase-12 (MMP-12). PLoS ONE 7(4):e35115
pubmed: 22509390 pmcid: 3324426 doi: 10.1371/journal.pone.0035115
Sumii T, Lo EH (2002) Involvement of matrix metalloproteinase in thrombolysis-associated hemorrhagic transformation after embolic focal ischemia in rats. Stroke 33(3):831–836
pubmed: 11872911 doi: 10.1161/hs0302.104542
Sun B-Z, Chen L, Wu Q, Wang H-L, Wei X-B, Xiang Y-X et al (2014) Suppression of inflammatory response by flurbiprofen following focal cerebral ischemia involves the NF-κB signaling pathway. Int J Clin Exp Med 7(9):3087
pubmed: 25356186 pmcid: 4211836
Sun S, Zhou J, Li Z, Wu Y, Wang H, Zheng Q et al (2022) Progranulin promotes hippocampal neurogenesis and alleviates anxiety-like behavior and cognitive impairment in adult mice subjected to cerebral ischemia. CNS Neurosci Ther 28(5):775–787
pubmed: 35146924 pmcid: 8981488 doi: 10.1111/cns.13810
Tang W, Lu Y, Tian Q-Y, Zhang Y, Guo F-J, Liu G-Y et al (2011) The growth factor progranulin binds to TNF receptors and is therapeutic against inflammatory arthritis in mice. Science 332(6028):478–484
pubmed: 21393509 pmcid: 3104397 doi: 10.1126/science.1199214
Tangkeangsirisin W, Serrero G (2004) PC cell-derived growth factor (PCDGF/GP88, progranulin) stimulates migration, invasiveness and VEGF expression in breast cancer cells. Carcinogenesis 25(9):1587–1592
pubmed: 15117809 doi: 10.1093/carcin/bgh171
Tao J, Ji F, Wang F, Liu B, Zhu Y (2012) Neuroprotective effects of progranulin in ischemic mice. Brain Res 1436:130–136
pubmed: 22221732 doi: 10.1016/j.brainres.2011.11.063
Thundyil J, Manzanero S, Pavlovski D, Cully TR, Lok K-Z, Widiapradja A et al (2013) Evidence that the EphA2 receptor exacerbates ischemic brain injury. PLoS ONE 8(1):e53528
pubmed: 23308246 pmcid: 3538581 doi: 10.1371/journal.pone.0053528
Tian Q, Zhao Y, Mundra JJ, Gonzalez-Gugel E, Jian J, Uddin SM et al (2014) Three TNFR-binding domains of PGRN act independently in inhibition of TNFα binding and activity. Front Biosci (landmark Ed) 19:1176
pubmed: 24896343 doi: 10.2741/4274
Toh H, Cao M, Daniels E, Bateman A (2013) Expression of the growth factor progranulin in endothelial cells influences growth and development of blood vessels: a novel mouse model. PLoS ONE 8(5):e64989
pubmed: 23741441 pmcid: 3669103 doi: 10.1371/journal.pone.0064989
Torroglosa A, Murillo-Carretero M, Romero-Grimaldi C, Matarredona ER, Campos-Caro A, Estrada C (2007) Nitric oxide decreases subventricular zone stem cell proliferation by inhibition of epidermal growth factor receptor and phosphoinositide-3-kinase/Akt pathway. Stem Cells 25(1):88–97
pubmed: 16960136 doi: 10.1634/stemcells.2006-0131
Van Kampen JM, Kay DG (2017) Progranulin gene delivery reduces plaque burden and synaptic atrophy in a mouse model of Alzheimer’s disease. PLoS ONE 12(8):e0182896
pubmed: 28837568 pmcid: 5570501 doi: 10.1371/journal.pone.0182896
Van Damme P, Van Hoecke A, Lambrechts D, Vanacker P, Bogaert E, Van Swieten J et al (2008) Progranulin functions as a neurotrophic factor to regulate neurite outgrowth and enhance neuronal survival. J Cell Biol 181(1):37–41
pubmed: 18378771 pmcid: 2287280 doi: 10.1083/jcb.200712039
Veltkamp R, Gill D (2016) Clinical trials of immunomodulation in ischemic stroke. Neurotherapeutics 13:791–800
pubmed: 27412685 pmcid: 5081130 doi: 10.1007/s13311-016-0458-y
Wang L, Zhang ZG, Zhang RL, Chopp M (2005) Activation of the PI3-K/Akt pathway mediates cGMP enhanced-neurogenesis in the adult progenitor cells derived from the subventricular zone. J Cereb Blood Flow Metab 25(9):1150–1158
pubmed: 15815584 doi: 10.1038/sj.jcbfm.9600112
Wang Q, Sun AY, Simonyi A, Kalogeris TJ, Miller DK, Sun GY et al (2007) Ethanol preconditioning protects against ischemia/reperfusion-induced brain damage: role of NADPH oxidase-derived ROS. Free Radical Biol Med 43(7):1048–1060
doi: 10.1016/j.freeradbiomed.2007.06.018
Wang BC, Liu H, Talwar A, Jian J (2015) New discovery rarely runs smooth: an update on progranulin/TNFR interactions. Protein Cell 6(11):792–803
pubmed: 26408020 pmcid: 4624682 doi: 10.1007/s13238-015-0213-x
Wang L, Liu H, Zhang L, Wang G, Zhang M, Yu Y (2017) Neuroprotection of dexmedetomidine against cerebral ischemia-reperfusion injury in rats: involved in inhibition of NF-κB and inflammation response. Biomol Ther 25(4):383
doi: 10.4062/biomolther.2015.180
Wang C, Zhang L, Ndong JDLC, Hettinghouse A, Sun G, Chen C et al (2019) Progranulin deficiency exacerbates spinal cord injury by promoting neuroinflammation and cell apoptosis in mice. J Neuroinflammation 16(1):1–12
pubmed: 30606213 pmcid: 6317220 doi: 10.1186/s12974-019-1630-1
Wang Y, Wang X, Li Y, Chen D, Liu Z, Zhao Y et al (2020) Regulation of progranulin expression and location by sortilin in oxygen–glucose deprivation/reoxygenation injury. Neurosci Lett 738:135394
pubmed: 32949659 doi: 10.1016/j.neulet.2020.135394
Willnow TE, Petersen CM, Nykjaer A (2008) VPS10P-domain receptors—regulators of neuronal viability and function. Nat Rev Neurosci 9(12):899–909
pubmed: 19002190 doi: 10.1038/nrn2516
Wu H, Siegel RM (2011) Progranulin resolves inflammation. Science 332(6028):427–428
pubmed: 21512023 pmcid: 3183821 doi: 10.1126/science.1205992
Xie S, Lu L, Liu L, Bi G, Zheng L (2016) Progranulin and short-term outcome in patients with acute ischaemic stroke. Eur J Neurol 23(3):648–655
pubmed: 26728399 doi: 10.1111/ene.12920
Xue Y, Zeng X, Tu W-J, Zhao J (2022) Tumor necrosis factor-α: The next marker of stroke. Dis Markers. https://doi.org/10.1155/2022/2395269
doi: 10.1155/2022/2395269 pubmed: 36618967 pmcid: 9822759
Yamaguchi Y, Pasquale EB (2004) Eph receptors in the adult brain. Curr Opin Neurobiol 14(3):288–296
pubmed: 15194108 doi: 10.1016/j.conb.2004.04.003
Yang Y, Liu P, Chen L, Liu Z, Zhang H, Wang J et al (2013) Therapeutic effect of Ginkgo biloba polysaccharide in rats with focal cerebral ischemia/reperfusion (I/R) injury. Carbohyd Polym 98(2):1383–1388
doi: 10.1016/j.carbpol.2013.07.045
Yang Y, Zhang X-J, Li L-T, Cui H-Y, Zhang C, Zhu C-H et al (2016) Apelin-13 protects against apoptosis by activating AMP-activated protein kinase pathway in ischemia stroke. Peptides 75:96–100
pubmed: 26631263 doi: 10.1016/j.peptides.2015.11.002
Yilmaz G, Granger DN (2008) Cell adhesion molecules and ischemic stroke. Neurol Res 30(8):783–793
pubmed: 18826804 pmcid: 2748428 doi: 10.1179/174313208X341085
Yin F, Banerjee R, Thomas B, Zhou P, Qian L, Jia T et al (2010) Exaggerated inflammation, impaired host defense, and neuropathology in progranulin-deficient mice. J Exp Med 207(1):117–128
pubmed: 20026663 pmcid: 2812536 doi: 10.1084/jem.20091568
Yoshida A, Yoshida S, Khalil AK, Ishibashi T, Inomata H (1998) Role of NF-kappaB-mediated interleukin-8 expression in intraocular neovascularization. Invest Ophthalmol vis Sci 39(7):1097–1106
pubmed: 9620068
Zhang K, Y-j Li, Feng D, Zhang P, Y-t W, Li X et al (2017) Imbalance between TNFα and progranulin contributes to memory impairment and anxiety in sleep-deprived mice. Sci Rep 7(1):1–12
Zhu Y, Gao Y, Zheng D, Shui M, Yu K, Liu X et al (2017) Design and evaluation of EphrinA1 mutants with cerebral protective effect. Sci Rep 7(1):1881
pubmed: 28507312 pmcid: 5432519 doi: 10.1038/s41598-017-02091-7

Auteurs

Daryush Purrahman (D)

Thalassemia and Hemoglobinopathy Research Center, Health Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.

Ali Shojaeian (A)

Research Center for Molecular Medicine, Hamadan University of Medical Sciences, Hamadan, Iran.

Łukasz A Poniatowski (ŁA)

Department of Neurosurgery, Dietrich-Bonhoeffer-Klinikum, Salvador-Allende-Straße 30, 17036, Neubrandenburg, Germany.

Bartłomiej Piechowski-Jóźwiak (B)

Neurological Institute, Cleveland Clinic Abu Dhabi, 59 Hamouda Bin Ali Al Dhaheri Street, Jazeerat Al Maryah, PO Box 112412, Abu Dhabi, United Arab Emirates.

Mohammad-Reza Mahmoudian-Sani (MR)

Thalassemia and Hemoglobinopathy Research Center, Health Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran. mohamadsani495@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH